Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases
Ended Project Grant Awarded Last action
- Award ID
- R43EY030821
- Recipient
-
Abzyme Therapeutics LLC UEI H2MLEFWV36N6
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,989
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,989 |
Quick answers
Who received award R43EY030821?
R43EY030821 was awarded to Abzyme Therapeutics LLC by National Eye Institute (National Institutes of Health) on September 1, 2019.
How much is award R43EY030821 worth?
$299,989 has been obligated on R43EY030821.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award